Publications by authors named "Andrew X Zhu"

100Publications

Remembering Dr. Supriya "Shoop" Saha.

Oncologist 2020 Aug 24. Epub 2020 Aug 24.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2020-0710DOI Listing
August 2020

Ivosidenib for advanced IDH1-mutant cholangiocarcinoma - Authors' reply.

Lancet Oncol 2020 08;21(8):e371

Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; Jiahui International Cancer Center, Jiahui Health, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(20)30394-6DOI Listing
August 2020

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

N Engl J Med 2020 05;382(20):1894-1905

From the Jonsson Comprehensive Cancer Center, Geffen School of Medicine at UCLA, Los Angeles (R.S.F.), the City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte (D.L.), and Genentech, South San Francisco (W.V., S.H., Y.W.) - all in California; the People's Liberation Army Cancer Center, Jinling Hospital, Nanjing (S.Q.), and Roche Product Development (D.-Z.X., J.L., C.H.) and Jiahui International Cancer Center, Jiahui Health (A.X.Z.), Shanghai - all in China; National Cancer Center Hospital East, Kashiwa (M.I.), and Kindai University Faculty of Medicine, Osaka (M.K.) - both in Japan; University Medical Center Mainz, Mainz, Germany (P.R.G.); Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif (M.D.), and University Hospital La Croix-Rousse, Lyon (P.M.) - both in France; Seoul National University College of Medicine (T.-Y.K.) and Samsung Medical Center, Sungkyunkwan University School of Medicine (H.Y.L.) - both in Seoul, South Korea; N.N. Blokhin Russian Cancer Research Center, Moscow (V.B.); the University of Texas M.D. Anderson Cancer Center, Houston (A.O.K.); Hoffmann-La Roche, Mississauga, ON, Canada (S.M.); Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston (A.X.Z.); and the National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei (A.-L.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1915745DOI Listing
May 2020

Evolution of Systemic Therapy for Hepatocellular Carcinoma.

Hepatology 2020 May 7. Epub 2020 May 7.

Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114-2696, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.31306DOI Listing
May 2020

Systemic therapies for intrahepatic cholangiocarcinoma.

J Hepatol 2020 02;72(2):353-363

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.10.009DOI Listing
February 2020

Palliative External Beam Radiation Therapy for Hepatocellular Carcinoma With Right Atrial Tumor Thrombus.

Pract Radiat Oncol 2020 May - Jun;10(3):e183-e187. Epub 2020 Jan 10.

Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2019.12.010DOI Listing
January 2020

Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.

Liver Int 2019 12 11;39(12):2214-2229. Epub 2019 Sep 11.

Massachusetts General Hospital Cancer Center, Harvard Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.14223DOI Listing
December 2019

Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study.

Lancet Gastroenterol Hepatol 2019 09 9;4(9):711-720. Epub 2019 Jul 9.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30189-XDOI Listing
September 2019

Nivolumab with gemcitabine plus cisplatin for biliary cancers: as easy as ABC?

Lancet Gastroenterol Hepatol 2019 08 17;4(8):575-577. Epub 2019 May 17.

Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30148-7DOI Listing
August 2019

Another Treatment Option for Advanced Hepatocellular Carcinoma With Portal Vein Thrombosis in China.

JAMA Oncol 2019 07;5(7):938-939

Department of Medicine, Massachusetts General Hospital Cancer Center, Boston.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2019.0249DOI Listing
July 2019

RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma.

Future Oncol 2019 Jun 10;15(16):1811-1822. Epub 2019 Apr 10.

Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0097DOI Listing
June 2019

Has PD-1 MET Its Match in Hepatocellular Carcinoma?

Gastroenterology 2019 05 26;156(6):1563-1565. Epub 2019 Mar 26.

Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00165085193458
Publisher Site
http://dx.doi.org/10.1053/j.gastro.2019.03.029DOI Listing
May 2019

Predictors of adjuvant treatment and survival in patients with intrahepatic cholangiocarcinoma who undergo resection.

Am J Surg 2019 11 4;218(5):959-966. Epub 2019 Mar 4.

Department of Surgery, Massachusetts General Hospital, Boston, MA, 02114, USA; Newton Wellesley Hospital, Newton, MA 02462, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2019.02.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722029PMC
November 2019

Current status and evolving treatment for primary liver cancers.

Chin Clin Oncol 2018 Oct;7(5):47

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://cco.amegroups.com/article/view/21987/21531
Publisher Site
http://dx.doi.org/10.21037/cco.2018.10.05DOI Listing
October 2018

Radiotherapy for Biliary Tract Cancers.

Semin Radiat Oncol 2018 10;28(4):342-350

Massachusetts General Hospital, Department of Radiation Oncology, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10534296183004
Publisher Site
http://dx.doi.org/10.1016/j.semradonc.2018.06.003DOI Listing
October 2018

Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy.

Semin Radiat Oncol 2018 10;28(4):332-341

Massachusetts General Hospital, Division of Hematology-Oncology, Department of Medicine, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2018.06.006DOI Listing
October 2018

Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.

Hepatology 2019 04 25;69(4):1803-1815. Epub 2019 Mar 25.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.30289
Publisher Site
http://dx.doi.org/10.1002/hep.30289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433548PMC
April 2019

Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased-Donor Liver Transplantation?

Hepatology 2019 03;69(3):1324-1336

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30278DOI Listing
March 2019

Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma.

Cardiovasc Intervent Radiol 2018 Nov 29;41(11):1799-1802. Epub 2018 May 29.

Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00270-018-1993-1DOI Listing
November 2018

Tivantinib for advanced hepatocellular carcinoma: is MET still a viable target?

Lancet Oncol 2018 05 3;19(5):591-592. Epub 2018 Apr 3.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30249-3DOI Listing
May 2018

Hepatocellular Carcinoma With Portal Venous Invasion: Radiating New Hope?

JAMA Oncol 2018 05;4(5):669-670

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2018.0007DOI Listing
May 2018

Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy.

Liver Cancer 2017 Nov 19;6(4):360-374. Epub 2017 Oct 19.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000481315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704715PMC
November 2017

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

J Clin Oncol 2018 01 28;36(3):276-282. Epub 2017 Nov 28.

Milind Javle and Rachna T. Shroff, The University of Texas MD Anderson Cancer Center, Houston, TX; Maeve Lowery and Ghassan K. Abou-Alfa, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY; Karl Heinz Weiss and Christoph Springfeld, Universitäts Klinikum Heidelberg, Heidelberg, Germany; Mitesh J. Borad, Ramesh K. Ramanathan, and Tanios Bekaii-Saab, Mayo Clinic, Phoenix, AZ; Lipika Goyal and Andrew X. Zhu, Massachusetts General Hospital Cancer Center, Boston, MA; Saeed Sadeghi and Richard S. Finn, David Geffen School of Medicine at UCLA; Anthony El-Khoueiry, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles; Robin Kate Kelley, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Teresa Macarulla, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ivan Borbath, Cliniques Universitaires Saint-Luc, Brussels; Eric Van Cutsem, University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium; Su Pin Choo, National Cancer Centre of Singapore, Singapore; Do-Youn Oh, Seoul National University, Seoul, South Korea; Philip A. Philip, Karmanos Cancer Institute, Detroit, MI; Li-Tzong Chen, National Institute of Cancer Research and National Cheng Kung University Hospital, Tainan; Kun-Huei Yeh, National Taiwan University Hospital Cancer Center, and Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan; Thanyanan Reungwetwattana, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Kristen Ciombor, The Ohio State University Wexner Medical Center, Columbus, OH; and Anuradha Patel, Suman Sen, Dale Porter, and Randi Isaacs, Novartis Pharmaceuticals Corporation, East Hanover, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075847PMC
January 2018

Can smart nanomedicine deliver effective targeted cytotoxic treatments to hepatocellular carcinomas while reducing the liver damage?

Hepatology 2018 03 30;67(3):826-828. Epub 2018 Jan 30.

Edwin L. Steele Laboratories, Department of Radiation Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.29617DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826834PMC
March 2018

Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer.

Pract Radiat Oncol 2018 May - Jun;8(3):179-184. Epub 2017 Sep 18.

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2017.09.008DOI Listing
September 2018

Recent developments in systemic therapy for hepatocellular carcinoma.

Authors:
Andrew X Zhu

Clin Adv Hematol Oncol 2017 Aug;15 Suppl 9(8):7-13

Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
August 2017

The treatment path in hepatocellular carcinoma.

Clin Adv Hematol Oncol 2017 Aug;15 Suppl 9(8):1-20

Indiana University School of Medicine, Indianapolis, Indiana.

View Article

Download full-text PDF

Source
August 2017

Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.

J Natl Cancer Inst 2017 09;109(9)

Department of Radiation Oncology, Department of Pathology, Division of Biostatistics, Department of Medicine, Division of Medical Oncology, Department of Medicine, Department of Radiology, and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx031DOI Listing
September 2017

Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis.

Hepatology 2018 01;67(1):422-435

Evidence-based Practice Center, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.29486
Publisher Site
http://dx.doi.org/10.1002/hep.29486DOI Listing
January 2018

Functional Imaging and Assessment of Antitumor Activity in Systemic Therapy for Hepatocellular Carcinoma.

Semin Liver Dis 2017 08 28;37(3):259-274. Epub 2017 Aug 28.

Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0037-1606254DOI Listing
August 2017

New Horizons for Precision Medicine in Biliary Tract Cancers.

Cancer Discov 2017 09 17;7(9):943-962. Epub 2017 Aug 17.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-17-0245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586506PMC
September 2017

Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose?

Pract Radiat Oncol 2017 Sep - Oct;7(5):e323-e329. Epub 2017 Feb 9.

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2017.02.001DOI Listing
May 2018

AASLD guidelines for the treatment of hepatocellular carcinoma.

Hepatology 2018 01;67(1):358-380

Digestive and Liver Diseases Division, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.29086DOI Listing
January 2018

Comparison of hepatocellular carcinoma in Eastern versus Western populations.

Cancer 2016 Nov 13;122(22):3430-3446. Epub 2016 Sep 13.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.30237
Publisher Site
http://dx.doi.org/10.1002/cncr.30237DOI Listing
November 2016

Liver-Directed Radiotherapy for Hepatocellular Carcinoma.

Liver Cancer 2016 Jul 10;5(3):198-209. Epub 2016 May 10.

Department of Radiation Oncology, Massachusetts General Hospital, Boston, Mass., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000367764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960357PMC
July 2016

Transarterial Chemoembolization in the Coming Era of Decreased Reimbursement for Readmissions.

J Am Coll Radiol 2016 Aug 18;13(8):915-21. Epub 2016 Jun 18.

Biomaterials Innovation Research Center, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts; Division of Vascular and Interventional Radiology, Mayo Clinic, Scottsdale, Arizona. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2016.04.030DOI Listing
August 2016

Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma.

J Hepatol 2016 08 27;65(2):296-304. Epub 2016 Apr 27.

Novartis Institutes for Biomedical Research, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.04.015DOI Listing
August 2016

The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.

Oncotarget 2016 Jul;7(29):46750-46767

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/8775
Publisher Site
http://dx.doi.org/10.18632/oncotarget.8775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216834PMC
July 2016

Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.

Oncologist 2016 05 21;21(5):594-9. Epub 2016 Mar 21.

Dana-Farber Cancer Institute, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861366PMC
May 2016

CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety.

J Vasc Interv Radiol 2016 Apr 28;27(4):496-502; quiz 503. Epub 2016 Feb 28.

Department of Radiology, Division of Interventional Radiology, Massachusetts General Hospital, White 270, Boston, MA 02114.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2016.01.010DOI Listing
April 2016

Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma.

Immunotherapy 2016 11;8(3):299-313. Epub 2016 Feb 11.

Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.15.126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619018PMC
December 2016

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

J Clin Oncol 2016 Feb 14;34(5):460-8. Epub 2015 Dec 14.

Theodore S. Hong, Jennifer Y. Wo, Beow Y. Yeap, Erin I. McDonnell, Lawrence S. Blaszkowsky, Eunice L. Kwak, Jill N. Allen, Jeffrey W. Clark, Lipika Goyal, Janet E. Murphy, John A. Wolfgang, Lorraine C. Drapek, Ronald S. Arellano, John T. Mullen, Sam S. Yoon, Kenneth K. Tanabe, Cristina R. Ferrone, David P. Ryan, Thomas F. DeLaney, and Andrew X. Zhu, Massachusetts General Hospital, Harvard Medical School; Harvey J. Mamon, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Edgar Ben-Josef, University of Pennsylvania Hospital, Philadelphia, PA; and Milind M. Javle and Christopher H. Crane, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/12/11/JCO.2015.64
Web Search
http://jco.ascopubs.org/content/suppl/2015/12/14/JCO.2015.64
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.64.2710
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.64.2710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872014PMC
February 2016

Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic Monotherapy.

PLoS One 2015 14;10(9):e0136725. Epub 2015 Sep 14.

3D Imaging Research, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0136725PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569468PMC
June 2016

Advanced Hepatocellular Carcinoma: Perfusion Computed Tomography-Based Kinetic Parameter as a Prognostic Biomarker for Prediction of Patient Survival.

J Comput Assist Tomogr 2015 Sep-Oct;39(5):687-96

From the *3D Imaging Research, Department of Radiology, Massachusetts General Hospital and Harvard Medical School; †Division of Abdominal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital; and ‡Massachusetts General Hospital Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/RCT.0000000000000288DOI Listing
December 2015